AFAM Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$8.3M Buy
60,111
+754
+1% +$100K 1.16% 21
2018
Q2
$7.2M Sell
59,357
-709
-1% -$88.5K 1.05% 28
2018
Q1
$7.7M Sell
60,066
-2,818
-4% -$381K 0.85% 36
2017
Q4
$8.79M Sell
62,884
-1,963
-3% -$273K 0.97% 22
2017
Q3
$8.43M Sell
64,847
-956
-1% -$127K 1.02% 20
2017
Q2
$8.71M Buy
65,803
+2,113
+3% +$270K 1.11% 16
2017
Q1
$7.93M Buy
63,690
+974
+2% +$116K 1.1% 19
2016
Q4
$7.23M Buy
62,716
+287
+0.5% +$33.2K 1.09% 18
2016
Q3
$7.38M Sell
62,429
-1,452
-2% -$176K 1.18% 17
2016
Q2
$7.75M Buy
63,881
+243
+0.4% +$27.6K 1.28% 10
2016
Q1
$6.89M Sell
63,638
-2,108
-3% -$218K 1.12% 21
2015
Q4
$6.75M Buy
65,746
+850
+1% +$85.5K 1.05% 28
2015
Q3
$6.06M Buy
64,896
+1,457
+2% +$141K 0.92% 39
2015
Q2
$6.18M Buy
63,439
+1,554
+3% +$156K 0.82% 49
2015
Q1
$6.23M Buy
61,885
+13,350
+28% +$1.36M 0.8% 50
2014
Q4
$5.08M Buy
48,535
+601
+1% +$63.3K 0.65% 69
2014
Q3
$5.11M Buy
47,934
+1,422
+3% +$147K 0.65% 69
2014
Q2
$4.87M Buy
46,512
+815
+2% +$82.4K 0.61% 76
2014
Q1
$4.49M Buy
+45,697
New +$4.24M 0.6% 80

Other funds holding JNJ

AFAM Capital's JNJ Position: Q3 2018 in Review

AFAM Capital increased its Johnson & Johnson (JNJ) stake by 1.3% in Q3 2018, buying an estimated $100K and bringing the position to 60,111 shares worth $8.3M. The position accounts for 1.16% of the portfolio, ranked #21.

AFAM Capital first reported a position in JNJ in Q1 2014 and has held it in 19 quarters since. The position peaked at $8.79M in Q4 2017. 2,583 funds tracked by Wall St. Rank hold JNJ as of Q3 2018.

  • AFAM Capital held 60,111 shares of Johnson & Johnson worth $8.3M as of Q3 2018.
  • AFAM Capital bought 754 Johnson & Johnson shares in Q3 2018, an estimated $100K.
  • Johnson & Johnson made up 1.16% of AFAM Capital's portfolio in Q3 2018, its #21 holding.
  • AFAM Capital first reported a position in Johnson & Johnson in Q1 2014 and has held it in 19 quarters since.
  • AFAM Capital's Johnson & Johnson position peaked at $8.79M in Q4 2017.
  • 2,583 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2018.

Based on AFAM Capital's 13F filing for Q3 2018, filed 14 Nov 2018.